Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
206.92
USD
+6.38 (+3.18%)
Official Closing Price
Updated: 7:59 PM EST, Mar 5, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,876,100
Open
201.13
Bid (Size)
207.10 (1)
Ask (Size)
207.60 (1)
Prev. Close
200.54
Today's Range
200.88 - 207.67
52wk Range
117.06 - 218.00
Shares Outstanding
1,085,430,420
Dividend Yield
1.64%
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
EMA issues advice on Lilly's bamlanivimab (LY-CoV555) alone and administered together with etesevimab (LY-CoV016) for the treatment of confirmed COVID-19 in the European Union
March 05, 2021
CHMP has completed a review of available data for both antibodies for the treatment of confirmed COVID-19
From
PR Newswire
Loxo Oncology at Lilly Announces Publication of Pirtobrutinib (LOXO-305) Phase 1/2 Data in The Lancet
March 05, 2021
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), today announced that The Lancet has published data from the pirtobrutinib (previously referred to as...
From
PR Newswire
Performance
YTD
+25.03%
+25.03%
1 Month
+2.63%
+2.63%
3 Month
+40.36%
+40.36%
6 Month
+38.58%
+38.58%
1 Year
+46.27%
+46.27%
More News
Read More
Tirzepatide achieved superior A1C and body weight reductions across all three doses compared to injectable semaglutide in adults with type 2 diabetes
March 04, 2021
From
PR Newswire
Baricitinib is First JAK-Inhibitor to Demonstrate Hair Regrowth in Phase 3 Alopecia Areata (AA) Trial
March 03, 2021
From
PR Newswire
Lilly announces additional doses of neutralizing antibody therapy purchased by U.S. government to treat COVID-19
February 26, 2021
From
PR Newswire
Should Investors Be Watching These Top Health Care Stocks Right Now?
March 02, 2021
Tags
Market News
From
StockMarket.com
U.S. Government to Purchase Minimum of 100,000 Doses of Etesevimab and Bamlanivimab Neutralizing Antibody Therapy
February 26, 2021
From
GlobeNewswire News Releases
EMA's Medicinal Committee Backs Eli Lilly's COVID-19 Antibody Therapy
March 05, 2021
Tags
Covid/19
Biotech
Market News
From
Benzinga
Eli Lilly's Tirzepatide Tops Novo's Semaglutide In Late-Stage Diabetes Study
March 04, 2021
Tags
LLY
General
Diabetes
From
Benzinga
Eli Lilly/Incyte's Baricitinib Shows Benefit In Patchy Hair Loss Disorder
March 03, 2021
Tags
News
Health Care
LLY
From
Benzinga
Vir Stock Craters On Weak Data For GSK-Partnered Covid Treatment
March 03, 2021
From
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.